GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Bard Financial Services Inc.

Bard Financial Services Inc. lowered its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 33.3% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 4,295 shares of the company’s stock after selling 2,145 shares during the quarter. Bard Financial Services Inc.’s holdings in GE HealthCare Technologies were worth $403,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of GEHC. Pathway Financial Advisers LLC bought a new stake in shares of GE HealthCare Technologies during the 1st quarter worth about $25,000. Fred Alger Management LLC purchased a new position in GE HealthCare Technologies during the second quarter valued at approximately $26,000. BNP Paribas acquired a new stake in GE HealthCare Technologies during the first quarter valued at $30,000. Rise Advisors LLC increased its holdings in GE HealthCare Technologies by 241.4% in the first quarter. Rise Advisors LLC now owns 338 shares of the company’s stock worth $31,000 after buying an additional 239 shares during the last quarter. Finally, Riverview Trust Co bought a new stake in GE HealthCare Technologies in the first quarter worth approximately $31,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock traded up $1.54 during mid-day trading on Friday, reaching $91.42. 1,988,678 shares of the stock traded hands, compared to its average volume of 3,075,668. The stock has a market capitalization of $41.73 billion, a PE ratio of 26.73, a price-to-earnings-growth ratio of 3.40 and a beta of 1.18. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.55. The business’s 50-day moving average is $86.25 and its 200-day moving average is $83.33.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.88 billion. During the same quarter in the previous year, the company posted $0.92 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up .5% on a year-over-year basis. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.13%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several research analyst reports. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 target price for the company. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their price objective for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research note on Wednesday, September 18th. Finally, Evercore ISI increased their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.23.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at $1,414,377.02. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.